series study has shown the promising effect of porcine submucosa matrix in healing of different kind of wounds.
METHODS:
The Healthcare Cost and Utilization Project Kids' Inpatient Database, the largest all-payer pediatric inpatient database, was queried by ICD-9 code for patients from 2000-2012 with a primary diagnosis of pectus excavatum admitted primarily for its repair. Independent t-tests and Mann Whitney U tests (for equal and unequal variances, respectively) as well as regressions with variables found to be significant on univariate analysis (p<0.05) were used to relate hospital charges and complications. Dollar values are in 2015 amounts.
RESULTS:
Nine thousand thirty-two patients were admitted for repair, of whom 85.0% were white and 16.5% were female. The average age was 14.17 years and the average length of stay was 4.64 days. 733 patients (8.1%) had "thorascopy" co-coded. 1,543 patients (17.1%) had at least one complication, the most common of which was iatrogenic pneumothorax (N=964, 10.7%), followed by post-operative pain (N=436, 4.8%) and pleural effusion (N=239, 2.6%). There were no injuries of the heart or lungs. Using binary logistic regression controlling for race, hospital size, hospital teaching status, age, and household income quartile, complications were more likely in large hospitals (OR 1.32, 1.15-1.53) and with increasing age (OR 1.06, 1.03-1.08). The average hospital charge was $41,015.58. Using linear regression, hospital charges were associated with western location ($13,070.78, p<0.0001), age ($429.33, p<0.0001), large hospital size ($1,121.92, p=0.18), length of stay ($8,254.58, p<0.0001), and number of procedures ($3,296.04, p<0.0001) and diagnoses ($1,750.76, p<0.0001).
CONCLUSIONS:
Pectus excavatum repair is a potentially complicated procedure, with nearly one fifth of patients suffering complications. Given isolated reports of cardiac injury associated with pectus excavatum repair, it was reassuring not to find this complication in this large, national sample.
1,2 The reasons for more common complications in larger hospitals should be explored for potential process changes that could lead to safer procedures; it is possible that these hospitals are managing more complicated cases. Due to insensitive ICD-9 codes for types of pectus excavatum repair, conclusions cannot be drawn about the outcomes of the Nuss versus Ravitch repairs; however, this is the largest study of complications and hospital charges associated with pectus excavatum repair. Nevertheless, little is known regarding the optimal timing or temperature of heat stress that is needed to achieve favorable results following hyperthermia therapy for muscle regeneration purposes. 2 The regeneration of skeletal muscle after injury is a highly complex and coordinated process that involves a multitude of cellular mechanisms. 3 The main objective of this study was to characterize the effects of hyperthermal therapy on the overall behavior of myoblasts during myogenic differentiation.
MATERIALS AND METHODS:
A murine C2C12 myoblast cell line was used in this study due to its morphological similarity to the primary myoblasts and its purity without contamination from other cell types. Various cellular processes, including myogenesis, myofibrillogenesis, hypertrophy/atrophy, and mitochondrial biogenesis, were examined using systematic cellular, morphological, and pathway-focused high-throughput gene expression profiling analyses.
RESULTS:
We found that C2C12 myoblasts exhibited distinctive time and temperature-dependence in biosynthesis and regulatory events during myogenic differentiation. Specifically, we for the first time observed that moderate hyperthermia at 39 °C favored the growth of sarcomere in myofibrils at the late stage of myogenesis, showing universal up-regulation of characteristic myofibril proteins. Characteristic myofibrillogenesis genes, including heavy polypeptide 1 myosin, heavy polypeptide 2 myosin, alpha 1 actin, nebulin and titin, were all significantly upregulated (p<0.01) after C2C12 cells differentiated at 39 °C over 5 days as compared to those at 37 °C. Furthermore, moderate hyperthermia enhanced myogenic differentiation, with nucleus densities per myotube showing 2.2-fold, 1.9-fold and 1.6-fold increases when C2C12 cells underwent myogenic differentiation at 39 °C over 24 hours, 48 hours and 72 hours, respectively, as compared to those differentiated at 37 °C. Yet, atrophy genes were sensitive even to moderate hyperthermia, indicating that strictly controlled heat stress is required to minimize the development of atrophy in myotubes. In addition, mitochondrial biogenesis was enhanced following thermal induction of myoblasts, suggesting a subsequent shift toward anabolic demand requirements for energy production.
CONCLUSION:
This study provides novel insight to the impact of hyperthermal therapy on regenerative forms of muscle healing and may provide greater understanding on the utility of bioengineered hyperthermal techniques in clinical medicines for those suffered with critical musculoskeletal injuries.
Disclosure/Financial support: Supported by The Johns Hopkins School of Medicine Research Grant. None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.

